作者单位:
Department of Hematology, Medical University of Gdansk, Poland
[1]
The National Hemophilia Center, Sheba Medical Center, Tel Hashomer, Israel
[2]
Division of Hematology/Oncology, School of Medicine, University of California at Davis, 4501 X St.,
[3]
Department of Disorders of Haemostasis and Internal Medicine, Institute of Haematology and
[4]
Center for Haemophilia and Thrombosis, Aarthus University Hospital, Skejby, Denmark
[5]
Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University
[6]
Bayer HealthCare Pharmaceuticals Inc., Montville, Montville, NJ, United States
[7]
Bayer Pharma AG, Wuppertal, Germany
[8]
Regional Reference Centre for Coagulation Disorders, Department of Clinical and Experimental
[9]
发布时间
2013-11-20